Cellavision AB Foreign (PK) (CLVSF)
USOTC
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current CLVSF market cap is 474.88M. The company's latest EPS is SEK 5.4633 and P/E is 3.64.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 461.77M | 471.44M | 565.55M | 639.34M | 677.29M |
| Operating Income | 126.58M | 110.27M | 162.73M | 158.27M | 167.05M |
| Net Income | 99.17M | 89.48M | 125.34M | 118.34M | 130.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 641.71M | 668.03M | 825.21M | 891.75M | 928.71M |
| Total Liabilities | 293.34M | 238.41M | 281.93M | 250.12M | 212.32M |
| Total Equity | 348.37M | 429.62M | 543.28M | 641.63M | 716.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | 125.99M | 71.12M | 159.72M | 137.29M | 196.44M |
| Investing | -266.3M | -34.96M | -84.34M | -70.01M | -85.53M |
| Financing | 72.98M | -35.22M | -48.48M | -90.41M | -97.04M |
| Market Cap | 474.88M |
| Price to Earnings Ratio | 3.64 |
| Price to Sales Ratio | 0.7 |
| Price to Cash Ratio | 3.9 |
| Price to Book Ratio | 0.66 |
| Dividend Yield | - |
| Shares Outstanding | 23.85M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -16.17% |
| 52 Week High | 25.905 |
| 52 Week Low | 19.91 |
| Spread (Intraday) | 1.66 (8.33%) |
| Company Name | Cellavision AB Foreign (PK) |
| Address |
ideon science park lund SE 223 70 |
| Website | https://www.cellavision.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
